Primary T-cell-based delivery platform for in vivo synthesis of engineered proteins.

Authors:
Radhakrishnan H; Newmyer SL; Ssemadaali MA; Javitz HS; Bhatnagar P.

Journal:
Bioeng Transl Med

Publication Year: 2023

DOI:
10.1002/btm2.10605

PMCID:
PMC10771566

PMID:
38193126

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
4D-CT deformable image registration using unsupervised recursive cascaded full-resolution residual …
Xu L; Jiang P; Tsui T and 4 more (2023) - Transparency Score: 3/6
Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflamm…
Deng C; Liu Q; Zhao H and 9 more (2023) - Transparency Score: 3/6
Adipose-derived stem cells enriched with therapeutic mRNA TGF-β3 and IL-10 synergistically promote …
Wang W; Chen L; Zhang Y and 5 more (2023) - Transparency Score: 4/6
Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic du…
Zhang H; Chen J; Hu X and 2 more (2023) - Transparency Score: 3/6
A drug-selectable acoustic reporter gene system for human cell ultrasound imaging.
Howells AR; Welch PJ; Kim J and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1: supporting information."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no competing financial interests."

Evidence found in paper:

"FUNDING INFORMATION Research reported in this publication was supported in part by the National Institute of Biomedical Imaging and Bioengineering (DP2EB024245: NIH Director's New Innovator Award Program, Office of the NIH Director, https://commonfund.nih.gov/newinnovator); the National Cancer Institute (R21CA236640 and R33CA247739) of the National Institutes of Health (NIH); and the Defense Advanced Research Projects Agency (DARPA) (D19AP00024: DARPA Young Faculty Award, https://www.darpa.mil/work-with-us/for-universities/young-faculty-award)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025